The applicability of eGFR equations to different populations.
about
The global burden of chronic kidney disease: estimates, variability and pitfalls.Maternal glomerular filtration rate in pregnancy and fetal sizeTriglyceride levels are closely associated with mild declines in estimated glomerular filtration rates in middle-aged and elderly Chinese with normal serum lipid levels.Fluctuation between fasting and 2-H postload glucose state is associated with glomerular hyperfiltration in newly diagnosed diabetes patients with HbA1c < 7%.Association of elevated glycosylated hemoglobin A1c with hyperfiltration in a middle-aged and elderly Chinese population with prediabetes or newly diagnosed diabetes: a cross-sectional studyEstimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis.An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.Creatinine-based equations for the adjustment of drug dosage in an obese population.An estimated glomerular filtration rate equation for the full age spectrum.Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort StudyNew Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors.Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?Serum uric acid is associated with lumbar spine bone mineral density in healthy Chinese males older than 50 years.Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate.Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease.Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?The conundrums of chronic kidney disease and aging.Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C.Chronic kidney disease: A likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease.Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies.The relationship between three eGFR formulas and hospitalization for heart failure in 54 486 individuals with type 2 diabetes.KDIGO Guidelines and Kidney Transplantation: Is the Cystatin-C Based Recommendation Relevant?Association Between Kidney Dysfunction and Carotid Atherosclerosis in Community-Based Older Adults in China.Characteristics and outcomes among patients with need for early dialysis after lung transplantation surgery.Lifetime Risk of CKD: What Does It Really Mean?Measured (and estimated) glomerular filtration rate: reference values in West Africa.Clinical value of urinary retinol-binding protein in ascites due to cirrhosis.Assessment of chronic kidney disease using skin texture as a key parameter: for South Indian population.Did Creatinine Standardization Give Benefits to the Evaluation of Glomerular Filtration Rate?Measurement of neutrophil gelatinase-associated lipocalin (NGAL) in patients with non-communicable diseases: any additional benefit?Single- versus multiple-sample method to measure glomerular filtration rate.Agreement between Chronic Kidney Disease Epidemiological Collaboration and Berlin Initiative Study equations for estimating glomerular filtration rate in older people: The Invecchiare in Chianti (Aging in Chianti Region) study.Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population.
P2860
Q30240087-19E51FA2-44A8-40A5-A3D9-7F13485BD157Q33864460-9861A1D7-E667-47BE-81C9-EE3858524EDDQ34281929-C60A6A27-5718-4BF4-A169-E4C341789E09Q34434682-83D6C9A0-7DAD-400F-9401-92655D483731Q35771676-485C56F9-6B39-4BCB-9B97-4AAF650CBDDDQ36275957-74FE1AC6-3DFD-485D-8C06-15A67F1FF834Q36736981-7C23654F-9559-41DB-8DAC-4CBCA04F8CC4Q36802097-0FB92FB0-A56B-484B-9C86-06394C343C06Q36846544-870FEB56-A86F-4D36-B0F6-F28E494B4E87Q37114337-78180B7F-572F-4EC3-8C4B-8EFE2AF999DEQ37244369-1B94B672-CAEA-408A-A464-6C20D723BE11Q37284118-2B69B44F-AD12-454D-8616-9B6103E42152Q37684637-CB20CAA6-8CC0-4052-8FE3-B391B10417C2Q38202919-300205FC-DF99-454C-9A2C-25E8E4093B67Q38848702-1601C10B-28C0-4FDF-A18C-0CF36CB7C758Q38966669-02DCCC4E-8506-4BFF-9B75-18CEDBB40CB7Q39019320-386B65DF-4C29-4E6D-B729-5A69463BBD1EQ39019336-0DCB6339-BD66-4D36-92A5-17A39C350CD7Q39309691-B35353B2-2347-46A5-AB5D-9F4DBB777C44Q39601367-83E4C931-4714-42F7-9E59-C0809FA5F69AQ40903705-22D39DC6-BC48-45B4-B980-6F1190A58EF8Q41161771-C163966A-B34C-432A-A005-9AFCE2FBA98CQ41731368-B5C2485F-9059-4737-AE8A-50759110BE3BQ42687848-F8EAEE1F-F1B6-46EC-A7E8-2B37DDD1C085Q43085093-18ED5163-AFE3-470B-BFE0-5F84C1E7B25AQ46599848-D75BC058-D0D3-4E6B-AA96-0AECF88F9DC6Q47155598-F81C082D-B7D3-4A99-9241-E1BF0D2DB48AQ47554528-340F8CF6-E9C1-412D-B4ED-EBC622E7997AQ47563517-15A8E0AE-08BB-40B8-8B41-FC5FDF1DAD76Q47636676-856AB517-6796-40BF-95F2-421E88928865Q48518034-6CC444CB-4CC4-49C7-B520-DCDEEBBC7884Q50539858-D0D9EB1F-DD86-45DB-8572-FC845BA18E9EQ50732583-350167E8-713C-497C-99CF-58FCED55DAC2Q52382377-5D874E2C-67FA-441F-80F5-988CABFAA18E
P2860
The applicability of eGFR equations to different populations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The applicability of eGFR equations to different populations.
@en
type
label
The applicability of eGFR equations to different populations.
@en
prefLabel
The applicability of eGFR equations to different populations.
@en
P2860
P356
P1476
The applicability of eGFR equations to different populations
@en
P2093
Christophe Mariat
P2860
P2888
P304
P356
10.1038/NRNEPH.2013.143
P407
P577
2013-07-16T00:00:00Z